Loading company…
Polyplus develops transfection reagents and plasmid manufacturing services for cell and gene therapies.
Polyplus supplies transfection reagents for gene and mRNA delivery, as well as plasmid manufacturing services for biotechnology and pharmaceutical customers. Founded in 2001 in France, the company serves biopharmaceutical companies and research institutions globally. Sartorius AG acquired Polyplus from ARCHIMED and Warburg Pincus for EUR 2.4 billion on March 31, 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in